Scientists recently discovered that glycyrrhizin, a substance taken from black licorice root, may reduce inflammation and ...

Researchers have developed a stem cell-based model of the human intestine that may transform how new IBD treatments are ...

Pharma Equity Group’s subsidiary Reponex takes key step forward in Inflammatory Bowel Disease with upcoming European patent grant May 11, 2026Announcement no. 7 Pharma Equity Group A/S today announces ...

Inflammatory bowel disease (IBD), affecting an estimated 6–8 million people worldwide, may soon be monitored with a simple ...

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...

Traditional epidemiological studies have identified numerous potential risk factors, but observational studies have struggled to establish causal links due to confounding factors and reverse causation ...

Chronic immune diseases are shaped by multiple inflammatory processes happening at the same time, each in different parts of ...

Mabwell’s IND application for 9MW5211 to treat inflammatory bowel disease receives US FDA clearance to begin clinical studies: Shanghai, China Monday, May 11, 2026, 18:00 Hrs [I ...

SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”) announced today that its NAMkind™ platform for intestinal efficacy prediction was recognized ...